MarginsXMarginsX
Home › Markets › Health Care › PGNY

Progyny Inc. (PGNY)

PGNY trades on Nasdaq in Health Care, Misc Health and Biotechnology Services. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$37.15
+2.68% on the day
Market cap
$2.7B
Mid cap
Revenue · 2025
$1.3B
+10.4% on 2024
Net income · 2025
$58.5M
4.5% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1551306/000155130626000020/0001551306-26-000020-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerPGNY on Nasdaq
SectorHealth Care
IndustryMisc Health and Biotechnology Services
CountryUnited States
IPO year2019
SEC CIK0001551306
SEC industry codeServices-Misc Health & Allied Services, NEC
Incorporated inDE

Financials · 2025

LineValue
Revenue$1.3B
Net income$58.5M
Operating income$85.3M
Net margin4.5%
Operating margin6.6%
Revenue growth+10.4%
Cash$112.2M
Total assets$742.4M
P/E (computed)46.8×
P/S (computed)2.1×

Warning signs

Cash runway
Cash-flow positive
$116.8M cash at September 30, 2026
Share count, 1 year
-14.6%
2025-10-31 to 2026-10-31 · -23.2% over 3 years
Going-concern doubt
No
10-Q filed November 5, 2026
Insider net buying, 12 months
-$643K
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-05
Cash and burn$116.8M cash; operating cash flow $51.8M a quarter.Report 2026-09-30
Shares outstanding73,647,334 (2026-10-31); 86,211,654 a year earlier; 95,836,228 three years earlier.Cover page 2026-10-31
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorErnst & Young LLP, New York, New York, United StatesPCAOB Form AP 2026-03-06
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $1.9M, sold $2.6M on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$341.3M$26.3M$56.6M$116.8MNo debt tags$1.3B10-Q 2026-11-05
Q2 2026
2026-06-30
$350.5M$28.1M$50.4M$152.6MNo debt tags$1.3B10-Q 2026-08-07
Q1 2026
2026-03-31
$328.5M$24.2M$45.9M$131.6MNo debt tags$1.3B10-Q 2026-05-08
Q4 2025
2025-12-31
$318.4M$12.5M$54.2M$112.2MNo debt tags$1.3B10-K 2026-02-27
Q3 2025
2025-09-30
$313.3M$13.9M$50.7M$134.0MNo debt tags$1.3B10-Q 2026-11-05
Q2 2025
2025-06-30
$332.9M$17.1M$55.5M$132.5MNo debt tags$1.2B10-Q 2026-08-07
Q1 2025
2025-03-31
$324.0M$15.1M$49.8M$109.2MNo debt tags$1.2B10-Q 2026-05-08
Q4 2024
2024-12-31
$298.4M$10.5M$52.2M$162.3MNo debt tags$1.2B10-K 2026-02-27

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B42019-10-25
Latest annual report10-K2026-02-27
Latest quarterly / interim10-Q2026-11-05
Latest current report8-K2026-11-04
Latest proxyDEFA14A2026-04-10

Source: SEC EDGAR submissions feed, 945 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+3.8%
1 month+32.1%
3 months+39.7%
Year to date+40.9%
1 year+48.2%
From 52-week high-1.1%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Misc Health and Biotechnology Services

TickerCompanyPriceDayMarket cap
AGLagilon health inc.$116.75+0.94%$2.0B
SHCSotera Health Company$16.25-2.17%$4.6B
DVADaVita Inc.$174.22-0.19%$11.0B
FMSFresenius Medical Care AG$21.86-0.77%$12.2B
VMDViemed Healthcare Inc. Common Shares$9.15-0.22%$346.7M
PARKPark Dental Partners Inc.$19.72-8.24%$109.2M
CCELCryo-Cell International Inc.$4.55-6.19%$36.7M
MGRXMangoceuticals Inc.$0.1603+3.42%$3.6M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier